Three-dimensional optical coherence tomography of Barrett’s esophagus and buried glands beneath neosquamous epithelium following radiofrequency ablation

Desmond C. Adler(Massachusetts Institute of Technology), Hiroshi Mashimo(VA Boston Healthcare System), Chao Zhou(Washington University in St. Louis), James G. Fujimoto(IIT@MIT), Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region), Joseph M. Schmitt(GlobalFoundries (United States)), Lauren Becker(Harvard University), H-C Lee(Massachusetts Institute of Technology), Tsung-Han Tsai(Massachusetts Institute of Technology)
Endoscopy
September 1, 2009
10.1055/s-0029-1215045
Cited by 69

Related Papers

Radiofrequency Ablation in Barrett's Esophagus with Dysplasia
|New England Journal of Medicine|2009|1.4k
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Durability of Radiofrequency Ablation in Barrett's Esophagus With Dysplasia
|Gastroenterology|2011|455
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396
Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.
|Journal of Biological Chemistry|1993|375